Tg Therapeutics TGTX
NASDAQ TGTX
$55.78 -0.41 (-0.73%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Net Margin (2017 - 2026)

Updated

Tg Therapeutics (TGTX) posted Net Margin of 3.24% for Q2 2026, down 16.73 percentage points from 19.97% a year earlier and down 6.41 percentage points from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Net Margin (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Tg Therapeutics was 55.22%, up 41.90 percentage points year-over-year; for FY2025, it came in at 72.56%, up 65.45 percentage points from FY2024.

  • Annual Net Margin has increased for three consecutive years, with a five-year change of +183875.85 percentage points (FY2020 to FY2025).
  • In prior years, Tg Therapeutics' Net Margin was 7.11% in FY2024 (+1.68 pp), 5.42% in FY2023 (+8041.76 pp), -8036.34% in FY2022 (-2832.26 pp) and -5204.08% in FY2021 (+178599.21 pp).
  • The Q2 2026 figure stands as the lowest quarterly Net Margin since Q1 2024.
  • On a year-over-year basis, Net Margin increased in five of the last eight quarters, with an average year-over-year change of +29.77 percentage points.
  • The strongest year-over-year quarter for Net Margin in the past five years was Q4 2021, with a gain of 228131.18 percentage points; the weakest was Q4 2022, with a drop of 94067.29 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was 9.65% (Q1 2026), 11.96% (Q4 2025) and 241.73% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 21.86%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 21.27%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -8.04%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 22.61%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.81%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 23.62%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 32.99%
10 Tg Therapeutics 8.60 Bn 7.99 Bn 199.14 Mn 3.24%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.24%
Mar 31, 2026 9.65%
Dec 31, 2025 11.96%
Sep 30, 2025 241.73%
Jun 30, 2025 19.97%
Mar 31, 2025 4.19%
Dec 31, 2024 21.57%
Sep 30, 2024 4.63%
Jun 30, 2024 9.36%
Mar 31, 2024 -16.87%
Dec 31, 2023 -32.79%
Sep 30, 2023 68.71%
Jun 30, 2023 -296.19%
Mar 31, 2023 -502.78%
Dec 31, 2022 -98,088.75%
Sep 30, 2022 -38,104.26%
Jun 30, 2022 -6,819.87%
Mar 31, 2022 -3,423.26%
Dec 31, 2021 -4,021.46%
Sep 30, 2021 -4,218.57%
API Access

Tg Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=TGTX&period=max&api_key=YOUR_API_KEY